The second objective is to study the interaction of Syn-1 with mutated a-Syn to know about the overall binding characteristics, including the binding site residues of a-Syn for controlling this interaction-mediated toxicity leading to PD. The gene discussed is SYN1; the disease is Parkinson disease.